BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8878899)

  • 21. Selective reduction of 6-O-sulfation in heparan sulfate from transformed mammary epithelial cells.
    Safaiyan F; Lindahl U; Salmivirta M
    Eur J Biochem; 1998 Mar; 252(3):576-82. PubMed ID: 9546676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Control of cell proliferation by heparan sulfate and heparin-binding growth factors.
    Vlodavsky I; Miao HQ; Atzmon R; Levi E; Zimmermann J; Bar-Shavit R; Peretz T; Ben-Sasson SA
    Thromb Haemost; 1995 Jul; 74(1):534-40. PubMed ID: 8578521
    [No Abstract]   [Full Text] [Related]  

  • 23. Heparan sulfate hexasaccharide selectively inhibits cancer stem cells self-renewal by activating p38 MAP kinase.
    Patel NJ; Sharon C; Baranwal S; Boothello RS; Desai UR; Patel BB
    Oncotarget; 2016 Dec; 7(51):84608-84622. PubMed ID: 27705927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Internalization of basic fibroblast growth factor by CCL39 fibroblast cells. Involvement of heparan sulfate glycosaminoglycans.
    Gannoun-Zaki L; Pieri I; Badet J; Moenner M; Barritault D
    Ann N Y Acad Sci; 1991; 638():431-3. PubMed ID: 1785816
    [No Abstract]   [Full Text] [Related]  

  • 25. The C-terminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans.
    Brown JC; Sasaki T; Göhring W; Yamada Y; Timpl R
    Eur J Biochem; 1997 Nov; 250(1):39-46. PubMed ID: 9431988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidation of heparan sulphate by hypochlorite: role of N-chloro derivatives and dichloramine-dependent fragmentation.
    Rees MD; Pattison DI; Davies MJ
    Biochem J; 2005 Oct; 391(Pt 1):125-34. PubMed ID: 15932347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enzymatic preparation of heparin disaccharides as building blocks in glycosaminoglycan synthesis.
    Kim YS; Thanawiroon C; Bazin HG; Kerns RJ; Linhard RJ
    Prep Biochem Biotechnol; 2001 May; 31(2):113-24. PubMed ID: 11426699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican.
    Steinfeld R; Van Den Berghe H; David G
    J Cell Biol; 1996 Apr; 133(2):405-16. PubMed ID: 8609172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulphation and fibronectin-binding properties of heparan sulphate glycosaminoglycans from transformed cultured human keratinocytes.
    Brown KW
    Br J Cancer; 1987 Mar; 55(3):295-7. PubMed ID: 2436645
    [No Abstract]   [Full Text] [Related]  

  • 30. Tissue-specific binding by FGF and FGF receptors to endogenous heparan sulfates.
    Friedl A; Filla M; Rapraeger AC
    Methods Mol Biol; 2001; 171():535-46. PubMed ID: 11450267
    [No Abstract]   [Full Text] [Related]  

  • 31. Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships.
    McKeehan WL; Kan M
    Mol Reprod Dev; 1994 Sep; 39(1):69-81; discusison 81-2. PubMed ID: 7999363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation.
    Saksela O; Moscatelli D; Sommer A; Rifkin DB
    J Cell Biol; 1988 Aug; 107(2):743-51. PubMed ID: 2971068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of iduronate 2-sulphate residues in heparan sulphate. Evidence for an ordered polymeric structure.
    Turnbull JE; Gallagher JT
    Biochem J; 1991 Feb; 273 ( Pt 3)(Pt 3):553-9. PubMed ID: 1996955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure of a heparan sulphate oligosaccharide that binds to basic fibroblast growth factor.
    Habuchi H; Suzuki S; Saito T; Tamura T; Harada T; Yoshida K; Kimata K
    Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):805-13. PubMed ID: 1497618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of O-sulphate substituents on D-glucuronic acid units in heparin-related glycosaminoglycans using novel synthetic disaccharide standards.
    Razi N; Kreuger J; Lay L; Russo G; Panza L; Lindahl B; Lindahl U
    Glycobiology; 1995 Dec; 5(8):807-11. PubMed ID: 8720079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparan sulfate primed on beta-D-xylosides restores binding of basic fibroblast growth factor.
    Miao HQ; Fritz TA; Esko JD; Zimmermann J; Yayon A; Vlodavsky I
    J Cell Biochem; 1995 Feb; 57(2):173-84. PubMed ID: 7759555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decorin endocytosis: structural features of heparin and heparan sulphate oligosaccharides interfering with receptor binding and endocytosis.
    Hausser H; Kresse H
    Biochem J; 1999 Dec; 344 Pt 3(Pt 3):827-35. PubMed ID: 10585870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparan sulphate alterations in tumour cells.
    Winterbourne DJ; Khan Z
    Biochem Soc Trans; 1984 Jun; 12(3):540-1. PubMed ID: 6234192
    [No Abstract]   [Full Text] [Related]  

  • 39. Heparan sulfate proteoglycans play a dual role in regulating fibroblast growth factor-2 mitogenic activity in human breast cancer cells.
    Delehedde M; Deudon E; Boilly B; Hondermarck H
    Exp Cell Res; 1996 Dec; 229(2):398-406. PubMed ID: 8986623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disaccharide analysis and molecular mass determination to microgram level of single sulfated glycosaminoglycan species in mixtures following agarose-gel electrophoresis.
    Volpi N
    Anal Biochem; 1999 Sep; 273(2):229-39. PubMed ID: 10469494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.